The new screening tool is capable of assessing the risk of preeclampsia sooner, the test maker says
While it can't diagnose menopause, the test could help women address their symptoms sooner
Xella Health has launched what it calls the first AI precision health platform built for the XX chromosome. The company says it aims to address a...
UK biowearable startup Emm has raised £6.8m to launch what it claims will be the world’s first smart menstrual cup with connected app. The London-based company...
Bristol-based femtech firm Emm has raised US$9m in seed funding for its smart menstrual cup that tracks and analyses the menstrual cycle. Established in 2020 by...
Talkspace has partnered with women’s healthcare provider Tia to integrate mental health services into primary care across all stages of a woman’s life. The agreement will...
Digital health platform Ovia Health by Labcorp is aiming to plug a gap for postpartum support in the US via a new programme. It has launched...
The US cancer diagnostics start-up PreciseDx has secured US$20.7m in series B funding to “advance” AI-based cancer risk assessments. The round, which brings the company’s total...
By FinDBest IVF
Acclinate seeks to mobilise diverse communities to enhance equity in clinical trials
